M&R CAPITAL MANAGEMENT INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
M&R CAPITAL MANAGEMENT INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2021$25,000
-7.4%
1,5090.0%0.01%
-14.3%
Q1 2021$27,0000.0%1,5090.0%0.01%
+16.7%
Q4 2020$27,000
-22.9%
1,509
-25.0%
0.01%
-33.3%
Q3 2020$35,000
-2.8%
2,0120.0%0.01%
-10.0%
Q2 2020$36,000
+20.0%
2,0120.0%0.01%
+11.1%
Q1 2020$30,000
-33.3%
2,012
-12.6%
0.01%
-10.0%
Q4 2019$45,000
+15.4%
2,3030.0%0.01%
+11.1%
Q3 2019$39,000
-9.3%
2,303
-6.9%
0.01%
-10.0%
Q2 2019$43,000
+7.5%
2,474
+13.6%
0.01%
+11.1%
Q1 2019$40,0002,1770.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2019
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders